These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16243798)

  • 1. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex.
    Schwartz AG; Prysak GM; Murphy V; Lonardo F; Pass H; Schwartz J; Brooks S
    Clin Cancer Res; 2005 Oct; 11(20):7280-7. PubMed ID: 16243798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
    J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
    Skov BG; Fischer BM; Pappot H
    Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Minamiya Y; Ogawa J
    Clin Cancer Res; 2005 Jul; 11(14):5084-9. PubMed ID: 16033821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers.
    Wu CT; Chang YL; Shih JY; Lee YC
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):979-86. PubMed ID: 16214508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer.
    Oduwole OO; Li Y; Isomaa VV; Mäntyniemi A; Pulkka AE; Soini Y; Vihko PT
    Cancer Res; 2004 Oct; 64(20):7604-9. PubMed ID: 15492288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.
    Alì G; Donati V; Loggini B; Servadio A; Dell'Omodarme M; Prati MC; Camacci T; Lucchi M; Melfi F; Mussi A; Fontanini G
    Hum Pathol; 2008 Oct; 39(10):1465-73. PubMed ID: 18620727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
    Nose N; Sugio K; Oyama T; Nozoe T; Uramoto H; Iwata T; Onitsuka T; Yasumoto K
    J Clin Oncol; 2009 Jan; 27(3):411-7. PubMed ID: 19064969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.
    Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
    Clin Cancer Res; 2007 Jul; 13(14):4046-50. PubMed ID: 17634528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
    Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
    Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
    Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
    J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta is expressed in human colorectal adenocarcinoma.
    Witte D; Chirala M; Younes A; Li Y; Younes M
    Hum Pathol; 2001 Sep; 32(9):940-4. PubMed ID: 11567223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer.
    Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Ogawa J
    Anticancer Res; 2005; 25(6C):4693-8. PubMed ID: 16334162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma.
    Park JS; Jung WH; Kim JK; Hwang HK; Cho SI; Yoon DS; Chi HS; Kim BR
    J Surg Res; 2009 Mar; 152(1):104-10. PubMed ID: 18394649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of estrogen receptor alpha and beta expression in carcinogen-induced mammary gland tumors of rats.
    Kang JS; Jung NJ; Kim S; Kim DJ; Jang DD; Yang KH
    Eksp Onkol; 2004 Mar; 26(1):31-5. PubMed ID: 15112577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
    J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.